-
The association between oral contraceptive use and ovarian or breast cancer in BRCA1 or BRCA2 mutation carriers are qualitatively similar to associations reported in the general population.
-
This paper represents the largest collection of cases with central path review and provides better clarity to prognostic factors previously intimated from retrospective work.
-
It is indeed ironic that 16 years after the landmark Burris study, innovations in pancreatic cancer treatment still lack essential quality-of-life data.
-
Calculating 60-day mortality risk by these readily available parameters (ECOG PS and WBC) can be used to identify high-risk patients who may require heightened surveillance after standard or experimental chemotherapy or, alternatively, a reduction in treatment intensity.
-
Hopefully, as multi-institution, randomized trials are developed for second-line treatment of pancreatic cancer, CA19-9 levels will be included both pre- and post-first cycle treatment and responses compared with the established RECIST criteria.
-
In this large, retrospective cohort study, women with a history of bariatric surgery were at a small increased risk of both spontaneous and medically indicated preterm birth and small for gestational age births.
-
Long-term complications, particularly secondary cancers, were significantly more common in patients receiving whole pelvic radiation (vs brachytherapy alone) for early-stage endometrial cancer.
-
Women presenting for emergency contraception were offered a copper IUD or Plan B. Those who chose an IUD had a lower cumulative risk of unintended pregnancy at 1 year.
-
In a prospective cohort study, women with endometriomas (> 2 cm) were found to have a decrease in ovarian reserve parameters compared to healthy controls 1 and 6 months after the endometriomas were removed.
-
Bevacizumab added to chemotherapy, particularly paclitaxel and cisplatin, was efficacious in all response outcomes (objective response, progression-free survival, and overall survival) without diminution in quality of life or unacceptable toxicity.
